Cristina R Ferrone MD
Surgical Oncology (Other than Breast), Minimally Invasive Surgery
Chair of Surgery Cedars Sinai
Join to View Full Profile
8700 Beverly BoulevardNorth Tower 8215Los Angeles, CA 90004
Phone+1 310-248-8156
Dr. Ferrone is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a surgical oncologist focused on pancreas, liver, bile duct and duodenal masses and cancers.
I was on faculty at the Massachusetts General Hospital for 17 years and Prof of Surgery at Harvard Medical School.
I focus on clinical trials and have an NIH funded translational research laboratory.
Education & Training
Massachusetts General HospitalResidency, 1997 - 2004
Washington University in St. Louis School of MedicineClass of 1997
Certifications & Licensure
CA State Medical License 2023 - 2025
NH State Medical License 2021 - 2024
MA State Medical License 2006 - 2023
ME State Medical License 2020 - 2022
RI State Medical License 2021 - 2022
NY State Medical License 2000 - 2007
American Board of Surgery Surgery
Publications & Presentations
PubMed
- Which technical difficulty score can best predict postoperative outcomes after minimally invasive liver resections?Louisa Bolm, Martina Nebbia, Onofrio Catalano, Gabriella Lionetto, Johanna von Bresinsky
Langenbeck's Archives of Surgery. 2025-02-21 - TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids.Yi Sun, Luke Maggs, Apekshya Panda, Samuel J Wright, Angelina M Cicerchia
Cancer Immunology Research. 2025-02-03 - Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma.Jordan M Cloyd, Angela Sarna, Matthew J Arango, Susan E Bates, Manoop S Bhutani
JAMA Surgery. 2025-02-01
Press Mentions
Cedars-Sinai Cancer Director Stepping DownFebruary 18th, 2025- Study Identifies TBK1 as Key to Overcoming CAR T ResistanceJanuary 9th, 2025
- Larchmont Chronicle: Cedars-Sinai’s First Female Chair of Surgery Has Big PlansSeptember 17th, 2024
Grant Support
- Tumor downstaging with small molecule therapeutics to enhance Uveal Melanoma metastasis eradication by B7-H3 CAR T cellsCEDARS-SINAI MEDICAL CENTER2023–2025
- Tumor downstaging with small molecule therapeutics to enhance Uveal Melanoma metastasis eradication by B7-H3 CAR T cellsCEDARS-SINAI MEDICAL CENTER2023–2025
- Tumor downstaging with small molecule therapeutics to enhance Uveal Melanoma metastasis eradication by B7-H3 CAR T cellsCEDARS-SINAI MEDICAL CENTER2023–2025
Other Languages
- Italian, German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
